Impairment Accounting for Securities
First written in FY2020-Q2. 7 of 15 entries say "Mitigated", first in FY2022-Q1. Latest entry: FY2024.
The whole theme swung hardest in 2017: 8 of 23 companies on the "Worse" side.
29 other companies' latest entry also says "Mitigated".
- FY2024MitigatedAnnual report
「There were no impairment losses for the consolidated fiscal year.」
Impairment losses on securities fell from ¥42 million in the previous fiscal year to none in the current fiscal year. - FY2024-Q3MitigatedAnnual report
「There were no impairment losses for the cumulative third quarter of the consolidated fiscal year.」
The Bank recorded ¥42 million of impairment losses on securities in the previous fiscal year, but none in the cumulative third quarter of the current fiscal year. - FY2024-Q1WorsenedAnnual report
「Write-downs on equities and other securities ¥7 million ¥39 million」
Write-downs on equities and other securities increased from ¥7 million in the same period of the previous year to ¥39 million. - FY2023WorsenedAnnual report
「Impairment losses for the consolidated fiscal year were ¥42 million, comprising ¥7 million on equities and ¥35 million on foreign equities.」
The Bank recorded ¥42 million of impairment losses on securities in the current fiscal year, compared with none in the previous fiscal year. - FY2023-Q3WorsenedAnnual report
「Impairment losses for the cumulative third quarter of the consolidated fiscal year were ¥7 million, all on equities.」
The Bank recorded ¥7 million of impairment losses on securities during the cumulative third quarter, compared with none in the previous consolidated fiscal year. - FY2023-Q2MitigatedAnnual report
「There were no impairment losses for either the previous consolidated fiscal year or the interim consolidated accounting period.」
No impairment losses on securities were recorded during the interim consolidated accounting period. - FY2023-Q1MitigatedAnnual report
「Write-downs on equities and other securities ¥174 million ¥7 million」
Write-downs on equities and other securities decreased from ¥174 million in the same period of the previous year to ¥7 million. - FY2022MitigatedAnnual report
「There were no impairment losses for the consolidated fiscal year.」
Impairment losses on securities fell from ¥806 million in the previous fiscal year to none in the current fiscal year. - FY2022-Q3Impairment losses on securities increased year on yearAnnual report
「Write-downs on equities and other securities ¥306 million ¥589 million」
Write-downs on equities and other securities included in other ordinary expenses increased from ¥306 million in the same period of the previous year to ¥589 million in the cumulative third quarter. - FY2022-Q2MitigatedAnnual report
「Impairment losses for the interim consolidated accounting period were ¥524 million, all on equities.」
Impairment losses on securities decreased from ¥1,242 million in the same period of the previous year to ¥524 million, although all of the losses related to equities. - FY2022-Q1MitigatedAnnual report
「Write-downs on equities and other securities ¥381 million ¥174 million」
Write-downs on equities and other securities included in other ordinary expenses decreased from ¥381 million in the same period of the previous year to ¥174 million. - FY2021WorsenedAnnual report
「Impairment losses for the consolidated fiscal year were ¥806 million, comprising ¥773 million on equities and ¥33 million on bonds.」
Impairment losses on securities increased from ¥256 million in the previous fiscal year to ¥806 million, including ¥773 million on equities. - FY2021-Q2WorsenedAnnual report
「Impairment losses for the interim consolidated accounting period were ¥1,242 million, all on equities.」
Impairment losses on securities totaled ¥1,242 million in the interim period, exceeding the ¥256 million recorded in the previous fiscal year. All of the impairment losses related to equities. - FY2020Annual impairment losses on securities increasedAnnual report
「Impairment losses for the consolidated fiscal year were ¥256 million, comprising ¥154 million on equities and ¥102 million on bonds.」
Impairment losses on securities totaled ¥256 million for the fiscal year, up from ¥133 million disclosed for the interim period. - FY2020-Q2First statedAnnual report
「Impairment losses for the interim consolidated accounting period were ¥133 million, comprising ¥83 million on equities and ¥50 million on bonds.」
During the interim period, the Bank recorded impairment losses of ¥133 million on securities whose market value had fallen significantly with no prospect of recovery, comprising ¥83 million on equities and ¥50 million on bonds.